Cargando…

Dexamethasone: Fulminant amoebic colitis following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501317/ http://dx.doi.org/10.1007/s40278-021-03368-1

Ejemplares similares

Dexamethasone/prednisolone: Acute fulminant necrotising amoebic colitis: case report
Publicado: (2021)

Acute fulminant amoebic colitis: A Case report
por: Romero Cedeño, Carlos Alberto, et al.
Publicado: (2023)

Fulminant amoebic colitis in the era of computed tomography scan: A case report and review of the literature
por: Kinoo, Suman Mewa, et al.
Publicado: (2018)

Acute fulminant necrotizing amoebic colitis: a rare and fatal complication of amoebiasis: a case report
por: Gupta, Shilpi Singh, et al.
Publicado: (2009)

Fulminant necrotising amoebic colitis after corticosteroid therapy for severe COVID-19
por: Saini, Renu, et al.
Publicado: (2021)

Dexamethasone: Reactivation of amoebic infection: case report
Publicado: (2021)

Dexamethasone: Hyperglycaemia following off-label use: case report
Publicado: (2022)

Lethal multiple colon necrosis and perforation due to fulminant amoebic colitis: a surgical case report and literature review
por: Tomino, Takahiro, et al.
Publicado: (2021)

Dexamethasone: Adrenal insufficiency following off-label use: case report
Publicado: (2021)

Dexamethasone: Endogenous endophthalmitis following off-label use: case report
Publicado: (2021)

Dexamethasone: Nocardia infection followed by off-label use: case report
Publicado: (2021)

Dexamethasone: Adrenal insufficiency following off-label use : case report
Publicado: (2021)

Dexamethasone: Pulmonary mucormycosis following off-label use: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Bone marrow necrosis following off label treatment with dexamethasone: case report
Publicado: (2022)

Dexamethasone: Acute pulmonary histoplasmosis following Off-label use: case report
Publicado: (2021)

Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021)

Dexamethasone: Glucocorticoid-induced hyperglycaemia following off label use : case report
Publicado: (2022)

Dexamethasone: Sino-orbital mucormycosis following off-label use: case report
Publicado: (2022)

Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Fulminant Necrotising Amoebic Colitis of Whole of Large Bowel: A Rare Complication of a Common Infectious Disease
por: Beg, Mohd Yasir, et al.
Publicado: (2020)

Dexamethasone: Disseminated coccidioidomycosis and off label use: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Publicado: (2021)

Dexamethasone: Reactivation of Strongyloides stercoralis following off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Acute Fulminant Necrotizing Amoebic Colitis Leading to Intestinal Perforation and Peritonitis
por: Raj, Prince, et al.
Publicado: (2015)

Dexamethasone: Elizabethkingia meningoseptica sepsis following off-label treatment: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Dexamethasone: Spontaneous pneumomediastinum and subcutaneous emphysema following off label use: 4 case reports
Publicado: (2021)

Dexamethasone/tocilizumab: Rhino-orbital mucormycosis following off-label use: 11 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone/prednisolone: Avascular necrosis following off-label use:3 case reports
Publicado: (2021)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1p3seosuhs2kac7ovmngn06tcc